Comparative effectiveness of infliximab and adalimumab in Crohn’s disease and ulcerative colitis

INTRODUCTION: The availability of monoclonal antibodies to tumor necrosis factor α (anti-TNF) has revolutionized management of Crohn’s disease (CD) and ulcerative colitis (UC). However, limited data exists regarding comparative effectiveness of these agents to inform clinical practice. METHODS: This...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Inflamm Bowel Dis
Autori principali: Ananthakrishnan, Ashwin N., Cagan, Andrew, Cai, Tianxi, Gainer, Vivian S., Shaw, Stanley Y, Savova, Guergana, Churchill, Susanne, Karlson, Elizabeth W., Kohane, Isaac, Liao, Katherine P., Murphy, Shawn N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792716/
https://ncbi.nlm.nih.gov/pubmed/26933751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000754
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi